Health Care: Drugs

Sanofi (SNY: NYSE)

$51.75 n/a | n/a%
04/24/15 - 04:01 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 41.48B 45.99B 47.55B 45.44B
Cost of Sales 11.84B 11.51B 12.57B 11.23B
Gross Operating Profit 29.64B 34.48B 34.99B 34.21B
Selling, General, and Administrative Expenses 11.27B 12.21B 12.43B 11.47B
Research & Development 5.87B 6.59B 6.51B 6.24B
Operating Income before D & A (EBITDA) 12.50B 15.68B 16.04B 16.50B
Depreciation & Amortization 4.59B 7.69B 6.49B 7.20B
Interest Income 234.69M 150.52M 122.99M 181.45M
Other Income - Net 335.62M 1.00B 1.26B 1.40B
Special Income / Charges -336.84M -1.48B -408.65M -184.05M
Total Income Before Interest Expenses (EBIT) 7.64B 7.25B 9.02B 9.00B
Interest Expense 735.69M 845.09M 731.35M 715.44M
Pre-Tax Income 6.91B 6.40B 8.29B 8.28B
Income Taxes 1.42B 1.05B 1.50B 589.72M
Minority Interest 144.71M 218.18M 223.50M 312.36M
Net Income From Continuing Operations 5.48B 5.35B 6.79B 7.69B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 5.48B 5.35B 6.79B 7.69B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 5.34B 5.13B 6.57B 7.38B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
6.32B 7.25B 8.71B 9.58B
Preferred Dividends
Net Income Available To Common 5.48B 5.35B 6.79B 7.69B
Basic EPS from Continuing Ops. 2.03 1.94 2.49 2.79
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.03 1.94 2.49 2.79
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.03 1.94 2.49 2.79
Basic Normalized Net Income/Share 2.34 2.63 3.19 3.48
EPS fr Continuing Ops. 2.01 1.92 2.47 2.78
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.01 1.92 2.47 2.78
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 2.01 1.92 2.47 2.78
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.31 2.60 3.17 3.46
Dividends Paid per Share 1.91 1.86 1.69 1.76

Portfolios with SNY

Latest SNY Headlines from TheStreet

More Financial News for SNY

Press Releases for SNY

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter